Press

Beckley Waves Acquires Nue Life

Oct 26 • 3 min read

Strengthens its Network of Psychedelic Care Infrastructure Beckley Waves, the first venture studio focused on building and investing companies in the thriving psychedelic ecosystem to advance mental health and well-being, announced today the strategic acquisition of Nue Life, a leading ketamine-assisted therapy provider. Beckley Waves will continue Nue Life’s work to provide safe and scalable access…

Cybin Announces Grant of European Patent Protecting its Proprietary Deuterated Programs

Oct 26 • 3 min read

– European patent provides composition of matter and medical use protection for the Company’s proprietary deuterated psilocybin analog and deuterated DMT programs – – New European patent further strengthens intellectual property portfolio, which now includes 33 granted patents and over 170 pending applications – Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical…

Safe Supply Streaming Co. Ltd. Announces Appointment of Ronan Levy as President

Oct 26 • 4 min read

Levy, a pioneer in the cannabis and psychedelics industries, brings over 15 years of capital markets and legal experience to Safe Supply Safe Supply Streaming Co. Ltd. (CSE: SPLY) (“Safe Supply” or the “Company“), the first company investing in and incubating companies at the forefront of the third wave of drug policy reform, announced today…

Mydecine Provides Q4 2023 Business Update

Oct 26 • 5 min read

Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD with psychedelic therapeutics, is pleased to address its shareholders and provide a general update on the Company’s progress….

Hearings Commence for Lawsuit Denying Psilocybin Scheduling Change Request

Oct 26 • 4 min read

A federal appeals court panel has begun hearing arguments in a case involving a Seattle doctor who sued the U.S. Drug Enforcement Administration for denying his patients access to psilocybin therapy and who is now asking the federal government to reschedule the psychedelic. The suit is part of the Seattle-based doctor’s efforts to expand psilocybin access to…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435